Form 4 for SMMT Summit Therapeutics Inc.
Accepted 2022-05-25 00:00:00 ET · period of report 2022-05-23 · accession 0001104659-22-064838 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-25 | 2022-05-23 | SMMT | DUGGAN ROBERT W | CEO, Dir | J - Other | — | +21.1K | 67.68M | +0.0% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-23 | J | A | 21,135 | — | 67,683,589 | D | — | — | (F1) The shares of Common Stock were collateral for a loan made by the Reporting Person to a third party, and were transferred to the Reporting Person in full satisfaction of the loan. |